These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 21275828)

  • 1. Targeting of lysosomes by liposomes modified with octadecyl-rhodamine B.
    Koshkaryev A; Thekkedath R; Pagano C; Meerovich I; Torchilin VP
    J Drug Target; 2011 Sep; 19(8):606-14. PubMed ID: 21275828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening and optimization of ligand conjugates for lysosomal targeting.
    Meerovich I; Koshkaryev A; Thekkedath R; Torchilin VP
    Bioconjug Chem; 2011 Nov; 22(11):2271-82. PubMed ID: 21913714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lysosome-targeted octadecyl-rhodamine B-liposomes enhance lysosomal accumulation of glucocerebrosidase in Gaucher's cells in vitro.
    Thekkedath R; Koshkaryev A; Torchilin VP
    Nanomedicine (Lond); 2013 Jul; 8(7):1055-65. PubMed ID: 23199221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased apoptosis in cancer cells in vitro and in vivo by ceramides in transferrin-modified liposomes.
    Koshkaryev A; Piroyan A; Torchilin VP
    Cancer Biol Ther; 2012 Jan; 13(1):50-60. PubMed ID: 22336588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of the ultrasound-mediated intracellular delivery of liposomes and dextrans.
    Afadzi M; Strand SP; Nilssen EA; Måsøy SE; Johansen TF; Hansen R; Angelsen BA; de L Davies C
    IEEE Trans Ultrason Ferroelectr Freq Control; 2013 Jan; 60(1):21-33. PubMed ID: 23287910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of spherulites as a lipidic carrier for low and high molecular weight agents.
    Zhang P; Huang Y; Makhov AM; Gao X; Zhang P; Li S
    Pharm Res; 2013 Jun; 30(6):1525-35. PubMed ID: 23579481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracellular Distribution of Lipids and Encapsulated Model Drugs from Cationic Liposomes with Different Uptake Pathways.
    Takikawa M; Fujisawa M; Yoshino K; Takeoka S
    Int J Nanomedicine; 2020; 15():8401-8409. PubMed ID: 33149583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endocytosis of poly(ethylene oxide)-modified liposome by human lymphoblastoid cells.
    Higashi N; Sunamoto J
    Biochim Biophys Acta; 1995 Apr; 1243(3):386-92. PubMed ID: 7537102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surface modification of liposomes with rhodamine-123-conjugated polymer results in enhanced mitochondrial targeting.
    Biswas S; Dodwadkar NS; Sawant RR; Koshkaryev A; Torchilin VP
    J Drug Target; 2011 Aug; 19(7):552-61. PubMed ID: 21348804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of Lysosomal pH by Flow Cytometry Using FITC-Dextran Loaded Cells.
    Eriksson I; Öllinger K; Appelqvist H
    Methods Mol Biol; 2017; 1594():179-189. PubMed ID: 28456983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of gentamicin on the lysosomal system of cultured human proximal tubular cells. Endocytotic activity, lysosomal pH and membrane fragility.
    Regec AL; Trump BF; Trifillis AL
    Biochem Pharmacol; 1989 Aug; 38(15):2527-34. PubMed ID: 2474296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ligand-based targeted delivery of a peptide modified nanocarrier to endothelial cells in adipose tissue.
    Hossen MN; Kajimoto K; Akita H; Hyodo M; Ishitsuka T; Harashima H
    J Control Release; 2010 Oct; 147(2):261-8. PubMed ID: 20647023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment of subcellular fractionation techniques to monitor the intracellular fate of polymer therapeutics I. Differential centrifugation fractionation B16F10 cells and use to study the intracellular fate of HPMA copolymer - doxorubicin.
    Seib FP; Jones AT; Duncan R
    J Drug Target; 2006 Jul; 14(6):375-90. PubMed ID: 17092838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transferrin coupled vesicular system for intracellular drug delivery for the treatment of cancer: development and characterization.
    Vaidya B; Vyas SP
    J Drug Target; 2012 May; 20(4):372-80. PubMed ID: 22339366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficient introduction of macromolecules and oligonucleotides into brain capillary endothelial cells using HVJ-liposomes.
    Matsuo H; Okamura T; Chen J; Takanaga H; Ohtani H; Kaneda Y; Naito M; Tsuruo T; Sawada Y
    J Drug Target; 2000; 8(4):207-16. PubMed ID: 11144231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluorescein conjugates as indicators of subcellular pH. A critical evaluation.
    Geisow MJ
    Exp Cell Res; 1984 Jan; 150(1):29-35. PubMed ID: 6198189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Release and cellular acceptance of multiple drugs loaded silk fibroin particles.
    Shi P; Goh JC
    Int J Pharm; 2011 Nov; 420(2):282-9. PubMed ID: 21920418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral absorption enhancement of salmon calcitonin by using both N-trimethyl chitosan chloride and oligoarginines-modified liposomes as the carriers.
    Huang A; Su Z; Li S; Sun M; Xiao Y; Ping Q; Deng Y
    Drug Deliv; 2014 Aug; 21(5):388-96. PubMed ID: 24188463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracellular fate of octaarginine-modified liposomes in polarized MDCK cells.
    Fujiwara T; Akita H; Harashima H
    Int J Pharm; 2010 Feb; 386(1-2):122-30. PubMed ID: 19922779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fourier transformed spectral bio-imaging for studying the intracellular fate of liposomes.
    Huth U; Wieschollek A; Garini Y; Schubert R; Peschka-Süss R
    Cytometry A; 2004 Jan; 57(1):10-21. PubMed ID: 14699601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.